Recently Viewed
Clear All$0.25
$0.00 (0.00%)As on 25-Apr-2025 09:30EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$----
P/E Ratio
--
P/B Ratio
--
Industry P/E
--
Debt to Equity
--
ROE
--
ROCE
--
Div. Yield
--
Book Value
--
EPS
--
CFO
$-28.00 Mln
EBITDA
$-48.71 Mln
Net Profit
$-44.07 Mln
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW)
| 31.58 | 5.13 | 8.70 | -67.95 | -16.86 | -- | -- |
BSE Sensex
| 1.23 | 1.57 | 3.97 | 7.26 | 11.47 | 20.39 | 11.18 |
S&P Small-Cap 600#
| -5.82 | -5.34 | -13.73 | -6.30 | 5.30 | 2.98 | 5.53 |
2024
|
2023
|
|
---|---|---|
Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW)
| 11.66 | -8.11 |
S&P Small-Cap 600
| 7.01 | 13.89 |
BSE Sensex
| 8.10 | 18.74 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers... INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel. Read more
Co-Founder, CEO & Director
Mr. Dagi Shahar Ben-Noon
Co-Founder, CEO & Director
Mr. Dagi Shahar Ben-Noon
Headquarters
Ra'anana
Website
The share price of Inspira Technologies Oxy BHN Ltd Warrant (IINNW) is $0.25 (NASDAQ) as of 25-Apr-2025 09:30 EDT. Inspira Technologies Oxy BHN Ltd Warrant (IINNW) has given a return of -16.86% in the last 3 years.
Inspira Technologies Oxy BHN Ltd Warrant (IINNW) has a market capitalisation of -- as on 25-Apr-2025. As per Value Research classification, it is a Small Cap company.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Inspira Technologies Oxy BHN Ltd Warrant (IINNW) and enter the required number of quantities and click on buy to purchase the shares of Inspira Technologies Oxy BHN Ltd Warrant (IINNW).
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
The CEO & director of Mr. Dagi Shahar Ben-Noon. is Inspira Technologies Oxy BHN Ltd Warrant (IINNW), and CFO & Sr. VP is Mr. Dagi Shahar Ben-Noon.
There is no promoter pledging in Inspira Technologies Oxy BHN Ltd Warrant (IINNW).
Some of the close peers are:
Company | Market Cap($ Mln) |
---|
Inspira Technologies Oxy B.H.N. Ltd. Warrant (IINNW) | Ratios |
---|---|
Return on equity(%)
|
--
|
Operating margin(%)
|
--
|
Net Margin(%)
|
--
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Inspira Technologies Oxy BHN Ltd Warrant (IINNW) was $0 Mln.